TABLE 3

In vitro antiproliferative activity of JNJ-17029259

Cell Line IC50
μM
Human cancer cell lines
    HeLa 2.12 ± 0.31
    HCT-116 2.74 ± 0.25
    SK-OV-3 1.43 ± 0.18
    PC3 1.84 ± 0.22
    A375 1.28 ± 0.04
    MDA-MB-231 2.77 ± 0.73
Normal cell type
    MRC-5 3.43 ± 0.67
    HASMC 3.68 ± 0.40
    MS1 3.74 ± 0.07
    HUVEC non-VEGF—stimulated 2.57 ± 0.47
    HUVEC VEGF-stimulated 0.1a
  • a Estimated from data in Fig. 3 (n = 3).